Bryn Mawr Capital Management’s Royalty Pharma RPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$10.8M	Buy	300,126 +10,353	+4%	+$373K	0.59%	46
2025 Q1	$9.02M	Buy	289,773 +280,673	+3,084%	+$8.74M	0.54%	53
2024 Q4	$232K	Buy	9,100 +600	+7%	+$15.3K	0.01%	383
2024 Q3	$240K	Buy	+8,500	New	+$240K	0.01%	369